The Jakarta Post
HIV/AIDS and Hepatitis B (HBV) sufferers are expected to get wider access to quality medicines at affordable prices as local drug manufacturers now have the authorization to produce anti-retroviral medicines.
The drug manufacturers, however, will still have to pay the royalties for producing the patented drugs.
Local production of patented drugs has been made possible with the issuance of Presidential regulation (Perpres) No. 76/2012 on patented drugs on Sept. 3.
“We will ensure the availability of good-quality, safe and effective generic versions of anti-retroviral and anti-viral drugs,” said HM Subuh, infectious disease control director at the Health Ministry, in Jakarta on Wednesday.
Under the regulation, local drug manufacturers can produce and or import the generic versions of several drugs necessary for the treatment of HIV and HBV.